Modification of Alternative Splicing of Bcl-x Pre-mRNA in Bladder Cancer Cells
- Author:
Zhaohui ZHU
1
;
Shi'an XING
;
Ping CHENG
;
Fuqing ZENG
;
Gongcheng LU
Author Information
1. 华中科技大学同济医学院附属协和医院
- Keywords:
bladder cancer;
Bcl-x;
alternative splicing
- From:
Journal of Huazhong University of Science and Technology (Medical Sciences)
2006;26(2):213-216
- CountryChina
- Language:Chinese
-
Abstract:
To modify the splicing pattern of Bcl-x and compare the effect of this approach with that of the antisense gene therapy in BIU-87 cell line of bladder cancer, by using 5'-Bcl-x AS to target downstream alternative 5'-Bcl-x splice site to shift splicing from Bcl-xL to Bcl-xS and 3'-Bcl-x AS antisense to the 3'-splice site of exon Ⅲ in Bcl-x pre- mRNA to down regulation of Bcl-xL expression,the inhibitory effects on cancer cells by modification of alternative splicing and antisense gene therapy were observed and compared by microscopy, MTT Assay, RT-PCR, FACS, Westhern bloting and clone formation. The growth of cells BIU-87 was inhibited in a dose- and time-dependent manner. Its inhibitory effect began 12 h after the exposure, reaching a maximum value after 72h. The number of cells decreased in S phase and the number increased in G1 phase. The ability to form foci was reduced and the antisense gene therapy was approximately half as efficient as modification of alternative splicing in inducing apoptosis. It is concluded that modification of splicing pattern of Bcl-x pre-mRNA in bladder cancer cell BIU-87 is better than antisense gene therapy in terms of tumor inhibition.
